Southampton doctors make a breakthrough in lung cancer treatment

Southampton doctors make a breakthrough in lung cancer treatment

Southampton doctors make a breakthrough in lung cancer treatment

First published in News

DOCTORS in Southampton have discovered a new breakthrough in lung cancer treatment.

A study led by city clinicians has found a drug that can significantly slow down progression of terminal cancer by ‘blocking’ disease-triggering molecules in the lung.

The drug, Nintedanib, halves the annual decline in breathing capacity in patients with idiopathic pulmonary fibrosis (IPF), a condition which causes inflammation and scarring of the lung tissue and leaves sufferers with an average life expectancy of between three and five years.

The studies, led by Professor Luca Richeldi, a consultant in respiratory medicine at Southampton General Hospital, involved 1,066 patients from 205 centres in 24 countries.

He said: “These are exciting results and mean Nintedanib has the potential to offer patients a new direction in treating this aggressive disease.”

Comments (1)

Please log in to enable comment sorting

9:40pm Mon 19 May 14

mike coll says...

I sincerely hope it never helps my chain smoking horror of a sister, she is now in her mid 50s, I have the bottle of Rothchilds champagne sitting nicely in my cellar waiting for the day she breaths he last into her tar filled lungs. less than 5 years to go I calculate.
I sincerely hope it never helps my chain smoking horror of a sister, she is now in her mid 50s, I have the bottle of Rothchilds champagne sitting nicely in my cellar waiting for the day she breaths he last into her tar filled lungs. less than 5 years to go I calculate. mike coll
  • Score: 0

Comments are closed on this article.

Send us your news, pictures and videos

Most read stories

Local Info

Enter your postcode, town or place name

About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree